TrialBMC medicine2026

Efficacy and safety of cyclosporine plus luspatercept versus cyclosporine in newly diagnosed non-transfusion-dependent non-severe aplastic anemia: A prospective randomized trial.

Zhuxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.